Because the significance of postoperative surveillance and adjuvant therapy for patients with curatively resected pathological stage I NSCLC is a matter of great debate, further studies using larger samples are needed to investigate the utility of determining PCDH10 methylation status of patients with NSCLC. The gene discussed is PCDH10; the disease is non-small cell lung carcinoma.